Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy

Dystrophin is a long rod-shaped protein that connects the subsarcolemmal cytoskeleton to a complex of proteins in the surface membrane (dystrophin protein complex, DPC), with further connections via laminin to other extracellular matrix proteins. Initially considered a structural complex that protec...

Full description

Saved in:
Bibliographic Details
Published inPhysiological reviews Vol. 96; no. 1; pp. 253 - 305
Main Authors Allen, David G, Whitehead, Nicholas P, Froehner, Stanley C
Format Journal Article
LanguageEnglish
Published United States American Physiological Society 01.01.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Dystrophin is a long rod-shaped protein that connects the subsarcolemmal cytoskeleton to a complex of proteins in the surface membrane (dystrophin protein complex, DPC), with further connections via laminin to other extracellular matrix proteins. Initially considered a structural complex that protected the sarcolemma from mechanical damage, the DPC is now known to serve as a scaffold for numerous signaling proteins. Absence or reduced expression of dystrophin or many of the DPC components cause the muscular dystrophies, a group of inherited diseases in which repeated bouts of muscle damage lead to atrophy and fibrosis, and eventually muscle degeneration. The normal function of dystrophin is poorly defined. In its absence a complex series of changes occur with multiple muscle proteins showing reduced or increased expression or being modified in various ways. In this review, we will consider the various proteins whose expression and function is changed in muscular dystrophies, focusing on Ca(2+)-permeable channels, nitric oxide synthase, NADPH oxidase, and caveolins. Excessive Ca(2+) entry, increased membrane permeability, disordered caveolar function, and increased levels of reactive oxygen species are early changes in the disease, and the hypotheses for these phenomena will be critically considered. The aim of the review is to define the early damage pathways in muscular dystrophy which might be appropriate targets for therapy designed to minimize the muscle degeneration and slow the progression of the disease.
AbstractList Dystrophin is a long rod-shaped protein that connects the subsarcolemmal cytoskeleton to a complex of proteins in the surface membrane (dystrophin protein complex, DPC), with further connections via laminin to other extracellular matrix proteins. Initially considered a structural complex that protected the sarcolemma from mechanical damage, the DPC is now known to serve as a scaffold for numerous signaling proteins. Absence or reduced expression of dystrophin or many of the DPC components cause the muscular dystrophies, a group of inherited diseases in which repeated bouts of muscle damage lead to atrophy and fibrosis, and eventually muscle degeneration. The normal function of dystrophin is poorly defined. In its absence a complex series of changes occur with multiple muscle proteins showing reduced or increased expression or being modified in various ways. In this review, we will consider the various proteins whose expression and function is changed in muscular dystrophies, focusing on Ca 2+ -permeable channels, nitric oxide synthase, NADPH oxidase, and caveolins. Excessive Ca 2+ entry, increased membrane permeability, disordered caveolar function, and increased levels of reactive oxygen species are early changes in the disease, and the hypotheses for these phenomena will be critically considered. The aim of the review is to define the early damage pathways in muscular dystrophy which might be appropriate targets for therapy designed to minimize the muscle degeneration and slow the progression of the disease.
Dystrophin is a long rod-shaped protein that connects the subsarcolemmal cytoskeleton to a complex of proteins in the surface membrane (dystrophin protein complex, DPC), with further connections via laminin to other extracellular matrix proteins. Initially considered a structural complex that protected the sarcolemma from mechanical damage, the DPC is now known to serve as a scaffold for numerous signaling proteins. Absence or reduced expression of dystrophin or many of the DPC components cause the muscular dystrophies, a group of inherited diseases in which repeated bouts of muscle damage lead to atrophy and fibrosis, and eventually muscle degeneration. The normal function of dystrophin is poorly defined. In its absence a complex series of changes occur with multiple muscle proteins showing reduced or increased expression or being modified in various ways. In this review, we will consider the various proteins whose expression and function is changed in muscular dystrophies, focusing on Ca(2+)-permeable channels, nitric oxide synthase, NADPH oxidase, and caveolins. Excessive Ca(2+) entry, increased membrane permeability, disordered caveolar function, and increased levels of reactive oxygen species are early changes in the disease, and the hypotheses for these phenomena will be critically considered. The aim of the review is to define the early damage pathways in muscular dystrophy which might be appropriate targets for therapy designed to minimize the muscle degeneration and slow the progression of the disease.
Dystrophin is a long rod-shaped protein that connects the subsarcolemmal cytoskeleton to a complex of proteins in the surface membrane (dystrophin protein complex, DPC), with further connections via laminin to other extracellular matrix proteins. Initially considered a structural complex that protected the sarcolemma from mechanical damage, the DPC is now known to serve as a scaffold for numerous signaling proteins. Absence or reduced expression of dystrophin or many of the DPC components cause the muscular dystrophies, a group of inherited diseases in which repeated bouts of muscle damage lead to atrophy and fibrosis, and eventually muscle degeneration. The normal function of dystrophin is poorly defined. In its absence a complex series of changes occur with multiple muscle proteins showing reduced or increased expression or being modified in various ways. In this review, we will consider the various proteins whose expression and function is changed in muscular dystrophies, focusing on Ca(2+)-permeable channels, nitric oxide synthase, NADPH oxidase, and caveolins. Excessive Ca(2+) entry, increased membrane permeability, disordered caveolar function, and increased levels of reactive oxygen species are early changes in the disease, and the hypotheses for these phenomena will be critically considered. The aim of the review is to define the early damage pathways in muscular dystrophy which might be appropriate targets for therapy designed to minimize the muscle degeneration and slow the progression of the disease.Dystrophin is a long rod-shaped protein that connects the subsarcolemmal cytoskeleton to a complex of proteins in the surface membrane (dystrophin protein complex, DPC), with further connections via laminin to other extracellular matrix proteins. Initially considered a structural complex that protected the sarcolemma from mechanical damage, the DPC is now known to serve as a scaffold for numerous signaling proteins. Absence or reduced expression of dystrophin or many of the DPC components cause the muscular dystrophies, a group of inherited diseases in which repeated bouts of muscle damage lead to atrophy and fibrosis, and eventually muscle degeneration. The normal function of dystrophin is poorly defined. In its absence a complex series of changes occur with multiple muscle proteins showing reduced or increased expression or being modified in various ways. In this review, we will consider the various proteins whose expression and function is changed in muscular dystrophies, focusing on Ca(2+)-permeable channels, nitric oxide synthase, NADPH oxidase, and caveolins. Excessive Ca(2+) entry, increased membrane permeability, disordered caveolar function, and increased levels of reactive oxygen species are early changes in the disease, and the hypotheses for these phenomena will be critically considered. The aim of the review is to define the early damage pathways in muscular dystrophy which might be appropriate targets for therapy designed to minimize the muscle degeneration and slow the progression of the disease.
Author Whitehead, Nicholas P
Allen, David G
Froehner, Stanley C
Author_xml – sequence: 1
  givenname: David G
  surname: Allen
  fullname: Allen, David G
  organization: Sydney Medical School & Bosch Institute, University of Sydney, New South Wales, Australia; and Department of Physiology & Biophysics, University of Washington, Seattle, Washington
– sequence: 2
  givenname: Nicholas P
  surname: Whitehead
  fullname: Whitehead, Nicholas P
  organization: Sydney Medical School & Bosch Institute, University of Sydney, New South Wales, Australia; and Department of Physiology & Biophysics, University of Washington, Seattle, Washington
– sequence: 3
  givenname: Stanley C
  surname: Froehner
  fullname: Froehner, Stanley C
  organization: Sydney Medical School & Bosch Institute, University of Sydney, New South Wales, Australia; and Department of Physiology & Biophysics, University of Washington, Seattle, Washington
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26676145$$D View this record in MEDLINE/PubMed
BookMark eNpVkc9u2zAMxoWhRf-tL7BDoeOANZlkW1K0Q4EgWbsCbQMk29mQbTpRq0ieJAfzs_Rlq2Bd0fFCAh_5-0jwFB1YZwGhT5SMKWXZ124zBA-7MUkhxhmh7AM6SUI2ohklB-_qY3QawmNqY4yzI3SccS44LdgJep5WAWwN2LV4PoToXbfRFs918H0XA149gYGoDL7vQ20Ar_TaKqPt-hteOgNhPzdT2ZdLvARVR70DvPgzrMHiVQe1hnCJlW3wg45e10nSDeDEjxvAc9iBcd0WbNxT9ga9Uf5tjeEjOmyVCXD-ms_Qr-vvP2c_RneLm9vZ9G70mBMeR1CRhsqJEgVnVSVaoFJmbcVkLWRBQRWtbCuV5EoWE9HK_e0Zy4GLJudUkvwMXf3ldn21haZOC3llys7rrfJD6ZQu_1es3pRrtysLLie5ZAnw-RXg3e8eQiy3OtRgjLLg-lBSwUiRE5HL1Hrx3uvN5N9H8hfwy5Oo
ContentType Journal Article
Copyright Copyright © 2016 the American Physiological Society.
Copyright © 2016 the American Physiological Society 2016 American Physiological Society
Copyright_xml – notice: Copyright © 2016 the American Physiological Society.
– notice: Copyright © 2016 the American Physiological Society 2016 American Physiological Society
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1152/physrev.00007.2015
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1522-1210
EndPage 305
ExternalDocumentID PMC4698395
26676145
Genre Journal Article
Review
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAMS NIH HHS
  grantid: R01 AR056221
– fundername: NIAMS NIH HHS
  grantid: R01AR056221
– fundername: NINDS NIH HHS
  grantid: P01 NS04678
– fundername: NINDS NIH HHS
  grantid: R01 NS033145
– fundername: NINDS NIH HHS
  grantid: R01 NS33145
– fundername: NINDS NIH HHS
  grantid: R21 NS088691
– fundername: NIH
  grantid: RO1 NS33145; RO1AR056221; R21 NS088691; P01 NS04678
– fundername: National Health and Medical Research Council, Australia.
  grantid: 573732
– fundername: Raymond and Beverly Sackler Foundation
– fundername: Parent Project Muscular Dystrophy
GroupedDBID ---
-DZ
-~X
.-4
.55
.GJ
0VX
0WA
123
186
18M
29O
2WC
39C
3O-
4.4
53G
5VS
6TJ
79B
85S
8M5
9M8
AAFWJ
AAYJJ
AAYOK
ABCQX
ABHWK
ABJNI
ABKWE
ABOCM
ABPPZ
ABTAH
ACGFO
ACGFS
ACGOD
ACNCT
ACPRK
ADBBV
ADFNX
ADIYS
AENEX
AETEA
AFFNX
AFHKK
AGCDD
AGHSJ
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BKKCC
BTFSW
C1A
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
EMOBN
F5P
FJW
GX1
H13
H~9
IAO
IEA
IGS
IH2
IHR
INH
INR
IOF
IPO
ITBOX
ITC
J5H
KQ8
L7B
MVM
N9A
NEJ
NHB
NPM
OHT
OK1
P2P
PQQKQ
RAP
RHI
RPL
RPRKH
RWL
RXW
TAE
TAF
TN5
TR2
UBC
UKR
UQL
W8F
WH7
WHG
WOQ
X7M
XJT
XOL
XSW
YBH
YNT
YQI
YSK
YYP
ZCA
ZGI
ZXP
ZY4
7X8
5PM
ID FETCH-LOGICAL-j306t-eb0d198a7465bb7fe1992fb59c7941ea4f9fbaa74b9487f96676253e67d361903
ISSN 1522-1210
0031-9333
IngestDate Thu Aug 21 18:12:24 EDT 2025
Fri Jul 11 06:10:32 EDT 2025
Thu Apr 03 06:53:40 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Copyright © 2016 the American Physiological Society.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j306t-eb0d198a7465bb7fe1992fb59c7941ea4f9fbaa74b9487f96676253e67d361903
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/4698395
PMID 26676145
PQID 1750430739
PQPubID 23479
PageCount 53
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4698395
proquest_miscellaneous_1750430739
pubmed_primary_26676145
PublicationCentury 2000
PublicationDate 2016-01-01
PublicationDateYYYYMMDD 2016-01-01
PublicationDate_xml – month: 01
  year: 2016
  text: 2016-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Bethesda, MD
PublicationTitle Physiological reviews
PublicationTitleAlternate Physiol Rev
PublicationYear 2016
Publisher American Physiological Society
Publisher_xml – name: American Physiological Society
SSID ssj0005565
Score 2.6126943
SecondaryResourceType review_article
Snippet Dystrophin is a long rod-shaped protein that connects the subsarcolemmal cytoskeleton to a complex of proteins in the surface membrane (dystrophin protein...
SourceID pubmedcentral
proquest
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 253
SubjectTerms Animals
Calcium - metabolism
Calcium Signaling
Dystrophin - deficiency
Dystrophin - genetics
Dystrophin - metabolism
Gene Expression Regulation
Humans
Muscle Development
Muscle, Skeletal - metabolism
Muscle, Skeletal - pathology
Muscle, Skeletal - physiopathology
Muscular Dystrophies - genetics
Muscular Dystrophies - metabolism
Muscular Dystrophies - pathology
Muscular Dystrophies - physiopathology
Nitric Oxide - metabolism
Reactive Oxygen Species - metabolism
Regeneration
Reviews
Signal Transduction
Title Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy
URI https://www.ncbi.nlm.nih.gov/pubmed/26676145
https://www.proquest.com/docview/1750430739
https://pubmed.ncbi.nlm.nih.gov/PMC4698395
Volume 96
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF6FIiFeELQc4dIiAS-p0_j28hYKpYBSKmilvkU-dolBtaPYljB_hX_Ir2Bmd-3YIQ_Qlyjx-orn8xy738wQ8lwEYRA44cTwGYsNsMeRETD8GXoTbnHX8jiu6M5OvONz58OFezEY_O6wlqoyGsc_t-aVXEWqsA3kilmy_yHZ9qSwAb6DfOETJAyf_yTjaVTIFxMcvjd1Ua7y5SLNsKDmqlqWxejLd7ApmOw4q4oYOYPpV3S7VYbzZ6zkpLKzrBfWa_WoQ6n9Rp9-1HBN1ZteqRGcXj9JsZo_DKYJb-iRHc6RJNNUmtfa3E5v0ViyTVtlq-ugtojDni4ty370brw2F-AVLzQUAbgYjBej03b8aJXzJm0HeyJLLTfuzmaYm7MZ7TJV_440g7WryG3TYLaqoTHmWndb2KdFs2S1clftcnsg1pratTtG35a531vsiYv1aXGSCTsCyXVfpAP2dgaZLS8lwiwkDJuqPOZGFe_T2SH26rSZe41ctyCkkeH_-49rOpLrqW4b-o81CV6udfD35bGEtb7Wtshok-Db8ZjObpNbOtShU4XbO2TAs12yN83CMr-s6UvaPvx6l9yYaY7HHvmlUU1zQdeopg2qaYNqqlBNW1S_ohLTeBxgerRPGzxThWeq8bxPAc1UoZlKNFM4P6CZdtCMZ2nQ3N5GfZecH709Ozw2dAsR4xvEwqXBo0lisiD0Hc-NIl9wZFuLyGUx2CGTh45gIgphOGIQuQuGDxWQwT0_sT3wle17ZCfLM_6A0MSH4EI4TuKB12vBvokpwPcWfihiF3TckDxrBDEHFY3rbmHG86qYm9hCAW0pG5L7SjDzpaolM2_EOCR-T2TtDlj-vT-SpQtZBl7j6eGVj3xEbq5fwcdkp1xV_Am42GX0VGLzD3SA2HY
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Absence+of+Dystrophin+Disrupts+Skeletal+Muscle+Signaling%3A+Roles+of+Ca2%2B%2C+Reactive+Oxygen+Species%2C+and+Nitric+Oxide+in+the+Development+of+Muscular+Dystrophy&rft.jtitle=Physiological+reviews&rft.au=Allen%2C+David+G.&rft.au=Whitehead%2C+Nicholas+P.&rft.au=Froehner%2C+Stanley+C.&rft.date=2016-01-01&rft.pub=American+Physiological+Society&rft.issn=0031-9333&rft.eissn=1522-1210&rft.volume=96&rft.issue=1&rft.spage=253&rft.epage=305&rft_id=info:doi/10.1152%2Fphysrev.00007.2015&rft_id=info%3Apmid%2F26676145&rft.externalDocID=PMC4698395
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1522-1210&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1522-1210&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1522-1210&client=summon